Fusion of theEWSR1andATF1genes without expression of theMITF‐Mtranscript in angiomatoid fibrous histiocytoma
Citations Over TimeTop 10% of 2005 papers
Abstract
Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor that usually occurs in children and young adults. Only two cases of AFH with genetic rearrangements have been reported previously; both of these had a FUS-ATF1 fusion gene. We have studied an AFH from a 9-year-old boy whose tumor displayed a t(12;22)(q13;q12) as the sole cytogenetic aberration. FISH,RT-PCR, and sequence analyses revealed an EWSR1-ATF1 fusion gene that has previously been reported in clear cell sarcoma (CCS), a soft tissue sarcoma that is morphologically and clinically distinct from AFH. This study thus has demonstrated that the EWSR1-ATF1 chimera represents a fusion gene that can be associated with different tumor types. Simultaneous expression of the EWSR1-ATF1 and MITF-M transcripts in CCS has led to the proposal that the MITF-M promoter is transactivated by EWSR1-ATF1. The AFH, however, did not express the MITF-M transcript, supporting the theory that MITF-M expression in CCS is a reflection of its cellular origin, rather than a consequence of the presence of an EWSR1-ATF1 fusion protein. Activation of the EWSR1-ATF1 oncogene is probably an early step in the transformation process, but the overall gene expression patterns are likely to vary considerably between AFH and CCS, in keeping with their clinicopathologic differences.
Related Papers
- → Fifteen-year quest for microphthalmia-associated transcription factor target genes(2009)350 cited
- → MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance(2022)83 cited
- → Microphthalmia‐Associated Transcription Factor (MITF) is Required but is Not Sufficient to Induce the Expression of Melanogenic Genes(2003)113 cited
- Microphthalmia-associated transcription factor (MITF) - from Waardenburg syndrome genetics to melanoma therapy(2010)
- → Investigation of the relationship between MITF and POU3F2 expression and the notion of a "genetic switch" underlying phenotype switching in melanoma.(2014)